The DEX/CRH test for major depression: A potentially useful diagnostic test

Psychiatry Research

Volumn 208, Issue 2, 2013, Pages 131-139

  Mokhtari, Mohammadreza ^a,b   Arfken, Cynthia ^a   Boutros, Nash ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

Corticotropin releasing hormone; Dexamethasone; Dexamethasone suppression test (DST); Hypothalamic pituitary adrenal (HPA) axis; Major depressive disorder

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE;

ARTICLE; BIPOLAR DISORDER; DEXAMETHASONE CORTICOTROPIN RELEASING HORMONE TEST; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC VALUE; DISEASE SEVERITY; HAMILTON SCALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; META ANALYSIS; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; TEST RETEST RELIABILITY;

CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; HUMANS; HYDROCORTISONE; PITUITARY-ADRENAL FUNCTION TESTS; PREDICTIVE VALUE OF TESTS;

EID: 84879419974     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.09.032     Document Type: Article

References (54)

1. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Quality and Safety in Health Care 2003, 12:18-23. AGREE Collaboration.
2. APA Task Force on Laboratory Tests in Psychiatry The dexamethasone suppression test: an overview of its current status in psychiatry. American Journal of Psychiatry 1987, 144:1253-1262.
3. Arfken C.L., Carney S., Boutros N. Translating biological parameters into clinically-useful diagnostic tests. Current Psychiatry Reports 2009, 11:320-323.
4. Aubry J., Gervasoni N., Osiek C., Perret G., Rossier M., Bertschy G., Bondolfi G. The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients. Journal of Psychiatric Research 2007, 4:290-294.
5. Bardeleben U., Holsboer F. Cortisol response to a combined dexamethasone-human corticotropin-releasing hormone challenge in patients with depression. Journal of Neuroendocrinology 1989, 1:485-488.
6. Bax, L., 2010. MIX 2.0. Professional Software for Meta-Analysis in Excel. Version (2.0.1.2). BiostatXL. http://www.meta-analysis-made-easy.com.
7. Berger M., Krieg C., Bossert S., Schreiber W., von Zerssen D. Past and present strategies of research on the HPA-axis in psychiatry. Acta Psychiatrica Scandinavica. Supplementum 1988, 341:112-125.
8. Bossuyt P., Reitsma J., Bruns D. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clinical Chemistry 2003, 49:1-6.
9. Boutros N., Fraenkel L., Feingold A. A four-step approach for developing diagnostic tests in psychiatry: EEG in ADHD as a test case. The Journal of Neuropsychiatry and Clinical Neurosciences 2005, 17:455-464.
10. Boutros N., Arfken C. A four-step approach to developing diagnostic testing in psychiatry. Clinical EEG and Neuroscience 2007, 38:62-65.
11. Boutros N., Arfken C., Galderisi S., Warrick J., Pratt G., Iacono W. The Status of EEG abnormality as a diagnostic test for schizophrenia. Schizophrenia Research 2008, 99:225-237.
12. Boyle M., Brewer J., Funatsu M., Wozniak D., Tsien J., Izumi Y., Muglia L. Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:473-478.
13. Brooke S.M., de Haas-Johnson A.M., Kaplan J.R., Manuck S.B., Sapolsky R.M. Dexamethasone resistance among nonhuman primates associated with a selective decrease of glucocorticoid receptors in the hippocampus and a history of social instability. Neuroendocrinology 1994, 60:134-140.
14. Bruns D. The STARD initiative and the reporting of studies of diagnostic accuracy. Clinical Chemistry 2003, 49:19-20.
15. Carpenter L., Ross N., Tyrka A., Anderson G., Kelly M., Price L. Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls. Psychoneuroendocrinology 2009, 34:1208-1213.
16. Carroll B., Martin F., Davies B. Resistance to suppression by dexamethasone of plasma 11-O.H.C.S. levels in severe depressive illness. British Medical Journal 1968, 3:285-287.
17. Carroll B. The dexamethasone suppression test for melancholia. British Journal of Psychiatry 1982, 140:292-304.
18. Checkley S. The neuroendocrinology of depression and chronic stress. British Medical Bulletin 1996, 52:597-617.
19. Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers C, Krumm B, Heuser I The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test. Biological Psychiatry 1998, 43:762-766.
20. Ehlert U, Gaab J, Heinrichs M Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biological Psychology 2001, 57:141-152.
21. Erhardt A., Ising M., Unschuld P., Kern N., Lucae S., Pütz B., Uhr M., Binder E., Holsboer F., Keck M. Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Neuropsychopharmacology 2006, 31:2515-2522.
22. García A., Martí O., Vallès A., Dal-Zotto S., Armario A. Recovery of the hypothalamic-pituitary-adrenal response to stress. Effect of stress intensity, stress duration and previous stress exposure. Neuroendocrinology 2000, 72:114-125.
23. Gastpar M., Gilsdorf U., Abou-Saleh M., Ngo-Khac T. Clinical correlates of response to DST. The dexamethasone suppression test in depression: a World Health Organisation collaborative study. Journal of Affective Disorders 1992, 26:17-24.
24. Gaudiano B., Epstein-Lubow G., Miller I. Does the dexamethasone suppression test reliably discriminate between psychotic and nonpsychotic major depression? an exploratory analysis of potential confounds. The Journal of Nervous and Mental Disease 2009, 197:395-400.
25. Gervasoni N., Bertschy G., Osiek C., Perret G., Denis R., Golaz J., Rossier M., Bondolfi G., Aubry J. Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode. Journal of Psychiatric Research 2004, 38:553-557.
26. Green H., Kane J. The dexamethasone suppression test in depression. Clinical Neuropharmacology 1983, 6:7-24.
27. Guthrie S. The impact of dexamethasone pharmacokinetics on the DST: a review. Psychopharmacology Bulletin 1991, 27:565-576.
28. Heuser I., Yassouridis A., Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. Journal of Psychiatric Research 1994, 28:341-356.
29. Holsboer-Trachsler E., Stohler R., Hatzinger M. Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression. Psychiatry Research 1991, 38:163-171.
30. Ising M., Künzel H., Binder E., Nickel T., Modell S., Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Progress in Neuro-psychopharmacology & Biological Psychiatry 2005, 29:1085-1093.
31. Ising M., Horstmann S., Kloiber S., Lucae S., Binder E., Kern N., Künzel H., Pfennig A., Uhr M., Holsboer F. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression-a potential biomarker?. Biological Psychiatry 2007, 62:47-54.
32. Kunugi H., Urushibara T., Nanko S. Combined DEX/CRH test among Japanese patients with major depression. Journal of Psychiatric Research 2004, 38:123-128.
33. Kunugi H., Ida I., Owashi T., Kimura M., Inoue Y., Nakagawa S., Yabana T., Urushibara T., Kanai R., Aihara M., Yuuki N., Otsubo T., Oshima A., Kudo K., Inoue T., Kitaichi Y., Shirakawa O., Isogawa K., Nagayama H., Kamijima K., Nanko S., Kanba S., Higuchi T., Mikuni M. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a multicenter study. Neuropsychopharmacology 2006, 31:212-220.
34. Lammers C., Garcia-Borreguero D., Schmider J., Gotthardt U., Dettling M., Holsboer F., Heuser I. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II. Biological Psychiatry 1995, 38:803-807.
35. Modell S., Yassouridis A., Huber J., Holsboer F. Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology 1997, 65:216-222.
36. Mössner R., Mikova O., Koutsilieri E., Saoud M., Ehlis A., Müller N., Fallgatter A., Riederer P. Consensus paper of the WFSBP task force on biological markers: biological markers in depression. The World Journal of Biological Psychiatry 2007, 8:141-174.
37. Nierenberg A., Feinstein A. How to evaluate a diagnostic marker test. Lessons from the rise and fall of dexamethasone suppression test. Journal of the American Medical Association 1988, 259:1699-1702.
38. Oshima A., Yamashita S., Owashi T., Murata T., Tadokoro C., Miyaoka H., Kamijima K., Higuchi T. The differential ACTH responses to combined dexamethasone/CRH administration in major depressive and dysthymic disorders. Journal of Psychiatric Research 2000, 34:325-328.
39. Oshima A., Miyano H., Yamashita S., Owashi T., Suzuki S., Sakano Y., Higuchi T. Psychological, autonomic and neuroendocrine responses to acute stressors in the combined dexamethasone/CRH test: a study in healthy subjects. Journal of Psychiatric Research 2001, 35:95-104.
40. Pariante C., Miller A. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biological Psychiatry 2001, 49:391-404.
41. Ritchie J., Belkin B., Krishnan K., Nemeroff C., Carroll B. Plasma dexamethasone concentrations and the dexamethasone suppression test. Biological Psychiatry 1990, 27:159-173.
42. Rybakowski J., Twardowska K. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness. Journal of Psychiatric Research 1999, 33:363-370.
43. Sackett D. Clinical Epidemiology: A Basic Science for Clinical Medicine 1991, Lippincott Williams and Wilkins, Philadelphia.
44. Schmider J., Lammers C.H., Gotthardt U., Dettling M., Holsboer F., Heuser I.J. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I. Biological Psychiatry 1995, 38:797-802.
45. Sher L. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior. Scientific World Journal 2006, 6:1398-1404.
46. Sherman B., Pfohl B., Winokur G. Circadian analysis of plasma cortisol levels before and after dexamethasone administration in depressed patients. Archives of General Psychiatry 1984, 41:271-275.
47. Simeon D., Knutelska M., Yehuda R., Putnam F., Schmeidler J., Smith L. Hypothalamic-pituitary-adrenal axis function in dissociative disorders, post-traumatic stress disorder, and healthy volunteers. Biological Psychiatry 2007, 61:966-973.
48. Strauss S. Evidence-Based Medicine: How to Practice and Teach EBM 2005, Churchill Livingston, Edinburgh. 3rd ed.
49. Veen G., Derijk R., Giltay E., van Vliet I., van Pelt J., Zitman F. The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression. European Neuropsychopharmacology 2009, 19:409-415.
50. Vreeburg S., Hartman C., Hoogendijk W., van Dyck R., Zitman F., Ormel J., Penninx B. Parental history of depression or anxiety and the cortisol awakening response. British Journal of Psychiatry 2010, 197:180-185.
51. Vreeburg S., Hoogendijk W., van Pelt J., Derijk R., Verhagen J., van Dyck R., Smit J., Zitman F., Penninx B. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Archives of General Psychiatry 2009, 66:617-626.
52. Vreeburg S., Kruijtzer B., van Pelt J., van Dyck R., DeRijk R., Hoogendijk W., Smit J., Zitman F., Penninx B. Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology. Psychoneuroendocrinology 2009, 34:1109-1120.
53. Watson S., Gallagher P., Del-Estal D., Hearn A., Ferrier I., Young A. Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychological Medicine 2002, 32:1021-1028.
54. Watson S., Gallagher P., Smith M., Ferrier I., Young A. The dex/CRH test-is it better than the DST?. Psychoneuroendocrinology 2006, 31:889-894.